Logo image of ALWIT.PA

WITBE.NET (ALWIT.PA) Stock Fundamental Analysis

EPA:ALWIT - Euronext Paris - Matif - FR0013143872 - Common Stock - Currency: EUR

2.18  +0.09 (+4.31%)

Fundamental Rating

2

ALWIT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 75 industry peers in the IT Services industry. ALWIT may be in some trouble as it scores bad on both profitability and health. ALWIT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALWIT had negative earnings in the past year.
ALWIT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALWIT reported negative net income in multiple years.
Of the past 5 years ALWIT 4 years had a positive operating cash flow.
ALWIT.PA Yearly Net Income VS EBIT VS OCF VS FCFALWIT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

ALWIT's Return On Assets of -4.75% is on the low side compared to the rest of the industry. ALWIT is outperformed by 69.33% of its industry peers.
The Return On Equity of ALWIT (-16.51%) is worse than 74.67% of its industry peers.
Industry RankSector Rank
ROA -4.75%
ROE -16.51%
ROIC N/A
ROA(3y)1.4%
ROA(5y)-1.3%
ROE(3y)7.36%
ROE(5y)-9.31%
ROIC(3y)N/A
ROIC(5y)N/A
ALWIT.PA Yearly ROA, ROE, ROICALWIT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

ALWIT has a better Gross Margin (99.44%) than 93.33% of its industry peers.
ALWIT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALWIT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 99.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.7%
GM growth 5Y3.33%
ALWIT.PA Yearly Profit, Operating, Gross MarginsALWIT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80 100

More info and screens

3

2. Health

2.1 Basic Checks

ALWIT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALWIT has about the same amout of shares outstanding than it did 1 year ago.
ALWIT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALWIT has a worse debt to assets ratio.
ALWIT.PA Yearly Shares OutstandingALWIT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALWIT.PA Yearly Total Debt VS Total AssetsALWIT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 1.30, we must say that ALWIT is in the distress zone and has some risk of bankruptcy.
ALWIT has a worse Altman-Z score (1.30) than 72.00% of its industry peers.
ALWIT has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as ALWIT would need 7.90 years to pay back of all of its debts.
ALWIT has a worse Debt to FCF ratio (7.90) than 64.00% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that ALWIT is somewhat dependend on debt financing.
ALWIT has a Debt to Equity ratio of 0.59. This is comparable to the rest of the industry: ALWIT outperforms 45.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 7.9
Altman-Z 1.3
ROIC/WACCN/A
WACC6.5%
ALWIT.PA Yearly LT Debt VS Equity VS FCFALWIT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M

2.3 Liquidity

ALWIT has a Current Ratio of 1.57. This is a normal value and indicates that ALWIT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.57, ALWIT is doing good in the industry, outperforming 72.00% of the companies in the same industry.
ALWIT has a Quick Ratio of 1.41. This is a normal value and indicates that ALWIT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.41, ALWIT is in the better half of the industry, outperforming 74.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.41
ALWIT.PA Yearly Current Assets VS Current LiabilitesALWIT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALWIT have decreased strongly by -75.00% in the last year.
The Revenue for ALWIT has decreased by -14.33% in the past year. This is quite bad
Measured over the past years, ALWIT shows a small growth in Revenue. The Revenue has been growing by 4.02% on average per year.
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.48%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y17.29%
Revenue growth 5Y4.02%
Sales Q2Q%-0.03%

3.2 Future

ALWIT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.40% yearly.
Based on estimates for the next years, ALWIT will show a decrease in Revenue. The Revenue will decrease by -3.73% on average per year.
EPS Next Y-205.13%
EPS Next 2Y-42.26%
EPS Next 3Y-9.4%
EPS Next 5YN/A
Revenue Next Year-25.59%
Revenue Next 2Y-9.36%
Revenue Next 3Y-3.73%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALWIT.PA Yearly Revenue VS EstimatesALWIT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ALWIT.PA Yearly EPS VS EstimatesALWIT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALWIT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALWIT is valuated correctly with a Price/Forward Earnings ratio of 16.28.
ALWIT's Price/Forward Earnings ratio is in line with the industry average.
ALWIT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 16.28
ALWIT.PA Price Earnings VS Forward Price EarningsALWIT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALWIT is valued cheaper than 90.67% of the companies in the same industry.
ALWIT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 16.63
EV/EBITDA 4.74
ALWIT.PA Per share dataALWIT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

ALWIT's earnings are expected to decrease with -9.40% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.26%
EPS Next 3Y-9.4%

More info and screens

0

5. Dividend

5.1 Amount

ALWIT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WITBE.NET

EPA:ALWIT (3/7/2025, 7:00:00 PM)

2.18

+0.09 (+4.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)09-26 2024-09-26
Earnings (Next)04-22 2025-04-22/amc
Inst Owners3.28%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.98M
Analysts86.67
Price Target5.61 (157.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1125%
EPS NY rev (3m)-1125%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.8%
Revenue NY rev (3m)-9.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.28
P/S 0.39
P/FCF 16.63
P/OCF 2.24
P/B 1.58
P/tB N/A
EV/EBITDA 4.74
EPS(TTM)-0.23
EYN/A
EPS(NY)0.13
Fwd EY6.14%
FCF(TTM)0.13
FCFY6.01%
OCF(TTM)0.98
OCFY44.72%
SpS5.63
BVpS1.38
TBVpS-0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.75%
ROE -16.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 99.44%
FCFM 2.33%
ROA(3y)1.4%
ROA(5y)-1.3%
ROE(3y)7.36%
ROE(5y)-9.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.7%
GM growth 5Y3.33%
F-Score4
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 7.9
Debt/EBITDA 1.33
Cap/Depr 91.84%
Cap/Sales 14.99%
Interest Coverage N/A
Cash Conversion 159.22%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.41
Altman-Z 1.3
F-Score4
WACC6.5%
ROIC/WACCN/A
Cap/Depr(3y)164.21%
Cap/Depr(5y)173.82%
Cap/Sales(3y)21.79%
Cap/Sales(5y)22.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.48%
EPS Next Y-205.13%
EPS Next 2Y-42.26%
EPS Next 3Y-9.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y17.29%
Revenue growth 5Y4.02%
Sales Q2Q%-0.03%
Revenue Next Year-25.59%
Revenue Next 2Y-9.36%
Revenue Next 3Y-3.73%
Revenue Next 5YN/A
EBIT growth 1Y-8.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.58%
EBIT Next 3Y53.71%
EBIT Next 5YN/A
FCF growth 1Y124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.13%
OCF growth 3YN/A
OCF growth 5YN/A